Platelet Aggregation Devices Market to Reach USD 725.8 Million by 2028

The Global Platelet Aggregation Devices Market is expected to reach USD 725.8 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 6.5% from 2022 to 2028. The increasing prevalence of target diseases along with an increase in the geriatric population is anticipated to augment the growth of the market during the forecast period.

Key Findings:

• The product segment is expected to grow at a Significant Compound Annual Growth Rate (CAGR) during the forecast period. This is attributable to the increase in the adoption of automation of platelet aggregation testing procedures along with technological advancements in the field of sensors and detectors. Furthermore, the growing preference for automated instruments and improved patient compliance due to point-of-care testing analyzers is also supporting the segment growth.
• The clinical applications segment held a substantial share in 2021. This is owing to the increase in point-of-care testing (POCT) in many health care systems.
• The standalone hospital's segment is expected to grow at a Significant Compound Annual Growth Rate (CAGR) during the forecast period. This is attributable to the various benefits offered by hospitals in platelet aggregation testing procedures, and the increased inpatient population.
• Asia Pacific is expected to grow at a considerable Compound Annual Growth Rate (CAGR) during the forecast period. This is attributable to the increase in investments for the development and modernization of healthcare infrastructure along with rising government initiatives for the advancement of the healthcare system in various emerging economies like China, and India in the region. Furthermore, the rising target population and increasing number of hospitals across developing countries is also augmenting the regional growth of the market.

Some of key players in Platelet Aggregation Devices Market include - Bio/Data Corporation (US), Helena Laboratories Corporation (US), WerfenLife (Spain),F.Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany)..

The increase in the geriatric population across the globe is expected to fuel the growth of the Platelet Aggregation Devices Market in the years to come. This is owing to the increasing levels of life expectancy and decreasing levels of fertility. According to the United Nations Department of Economic and Social Affairs, Population Division, the estimated persons aged 65 years or over in 2020 were 727 million globally. It is also projected that the number of older persons worldwide is projected to more than double over the next three decades, reaching over 1.5 billion in 2050. Almost all the regions are estimated to show an increase in the size of the older population between 2020 and 2050. Thus, the share of the population aged 65 years or above is expected to increase to around 16.0 percent in 2050 from 9.3 percent in 2020. This increase is expected to increase the demand for platelet aggregation devices in near future.

North America held the largest shares in 2021. This is attributable to the increase in platelet aggregation tests and treatments, technological advancements, and the rising number of surgeries in the region. Furthermore, the presence of supportive regulatory authorities in the countries like the U.S. and the strong presence of device manufacturers is also augmenting the regional growth of the market.